ArticleNeuro-oncology2015

Getting it first versus getting it right: weighing the value of and evidence for progression-free survival as a surrogate endpoint for overall survival in glioblastoma.

Brian M Alexander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.